�ۿ۴�ý

GSK doubles down on oncology as AstraZeneca’s pipeline cranks up

Executive pay and patent cliffs give clues to the future ahead of the pharma giants’ first-quarter results

ABF confirms Primark demerger as margins disappoint

Higher markdowns hurt Primark’s margins

Powerhouse stocks in the aerospace supply chain

From Rolls-Royce to GE, our City analyst Robin Hardy finds out which of the giant engine makers are worth backing

Metlen Energy and Metals reports strengthening revenues

The commercial backdrop has been far from favourable since the Greek group’s London debut

Berkeley’s profit warning casts a shadow over housebuilders

Other players in the sector may struggle to maintain dividends and buybacks

Is Games Workshop’s top-tier valuation worth it?

Deep Dive: A deal with Amazon should boost the global customer base, but can the company really keep growing?

Why the market is turning against Unilever’s $45bn food deal

Analysts are predicting a “complex and uncertain” 15 months for shareholders

Shareholders rally against $45bn Unilever food deal

Sale leaves the consumer goods giant focusing on household goods and personal care

Next keeps growing but warns on Middle East

The clothing retailer maintained its reputation for underpromising and overdelivering

Markets are wrong about this stock’s AI risk – now it’s a bargain

Anxiety over its future is rattling shareholders, but this tech stock is an AI winner, not a loser